William Vainchenker
25PUBLICATIONS
106CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (25)
Sort by Publication Date:
|Jan 09, 2026
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms.Stefan N Constantinescu, William Vainchenker, Christian Pecquet
|Aug 07, 2025
CD24 senescent neutrophils as key players in myelofibrosis.William Vainchenker, Nasrine Yahmi
|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.Nabih Maslah, Nina Kaci, Blandine Roux
|Sep 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN.Edimara S Reis, Rebecca Buonpane, Hamza Celik
|Jun 13, 2024
DNMT3A gates IFN-induced MPN HSC exhaustion.Stefan N Constantinescu, William Vainchenker
|Feb 20, 2024
Deregulation of the p19/CDK4/CDK6 axis in Jak2V617F megakaryocytes accelerates the development of myelofibrosis.Hélène Duparc, Delphine Muller, Laure Gilles
Pageof 5
Frequent Collaborators
10 joint publications
Isabelle Plo
8 joint publications
Hana Raslova
5 joint publications
Caroline Marty
5 joint publications
Stefan N Constantinescu
4 joint publications
Bruno Cassinat
3 joint publications
Nabih Maslah
3 joint publications
Lina Benajiba
3 joint publications
Jean-Jacques Kiladjian
2 joint publications
Emmanuelle Verger
2 joint publications
Rachel Petermann
